Recent advances in the development of EGFR degraders: PROTACs and LYTACs
D Hong, B Zhou, B Zhang, H Ren, L Zhu… - European Journal of …, 2022 - Elsevier
Abstract Epidermal Growth Factor Receptor (EGFR), a transmembrane tyrosine kinase
receptor, belongs to the ErbB receptor family, also known as HER1 or ErbB1. Its abnormal …
receptor, belongs to the ErbB receptor family, also known as HER1 or ErbB1. Its abnormal …
Management of Resistance to Targeted Therapy in EGFR Mutational Lung Adenocarcinoma: A Case Report
S Ermayanti - Bioscientia Medicina: Journal of Biomedicine and …, 2023 - bioscmed.com
Advances in diagnosis and treatment have enabled a targeted therapy approach to inhibit
tumor progression and provide a favorable prognosis. One of the targeted therapies in non …
tumor progression and provide a favorable prognosis. One of the targeted therapies in non …